DOC's Q2 earnings are likely to benefit from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
Get a deeper insight into the potential performance of Healthpeak (DOC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Healthpeak Properties is strategically focused on Class A outpatient and life science real estate, benefiting from demographic tailwinds and supply constraints in key markets. The recent Physicians Realty Trust merger enhances scale, operational synergies, and defensibility, positioning Healthpeak for steady FFO growth as sector fundamentals improve. Despite high leverage and capital allocation risks, Healthpeak trades at a significant discount to historical valuation multiples, offering attractive long-term total return potential.
Healthpeak Properties offers strong upside potential, driven by robust AFFO growth, merger synergies, and a well-covered 7% dividend yield. Recent earnings show double-digit revenue and AFFO growth, with management guiding for continued double-digit AFFO growth and solid same-store NOI in 2025. Share repurchases, a switch to monthly dividends, and a healthy balance sheet further support long-term price appreciation and income stability.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Healthpeak offers a nearly 7% yield, strong dividend coverage, and trades at a deep discount to private market value, making it a compelling buy. The merger with Physicians Realty Trust created a diversified, cost-efficient REIT with reliable income from medical offices and upside from labs and senior housing. Risks like soft lab demand and higher rates are cushioned by long leases, fixed debt, and strong outpatient/CCRC performance, ensuring dividend security.
DOC is a hold—stock trades near lows, post-merger integration is ongoing, and the market isn't buying the growth story yet. Merger with Physicians Realty Trust brings scale and diversification, but organic growth is lacking and integration risks remain. Valuation isn't compelling: payout ratio is stretched, margins are middling, and peers offer better value or growth opportunities.
Healthpeak Properties is trading at historically low valuations, offering a compelling 7% dividend yield with strong coverage and solid operating results. The REIT's diversified portfolio, consistent NOI growth, and defensive healthcare focus provide stability and resilience against macroeconomic shocks. Insider buying and share repurchases signal management's confidence in the stock's undervaluation and future upside potential.
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.
A dividend stock with 7%-plus yields and solid upside potential. The downside risk is also limited at current prices.
Fifteen years of investing and writing taught me that humility, perseverance, and financial literacy are essential for long-term success. Avoid market timing and emotional investing; focus on time in the market, sound fundamentals, and disciplined research-based decisions. Steer clear of high-yield, speculative REITs; prioritize blue-chip REITs with reliable income and growth prospects for wealth building.
Dividend stocks are worth loading up on, as significant uncertainty is still ahead.